Argatroban tPA stroke study: Study design and results in the first treated cohort Academic Article uri icon

Overview

MeSH Major

  • Pipecolic Acids
  • Stroke
  • Tissue Plasminogen Activator

abstract

  • The safety of low-dose argatroban combined with intravenous rtPA may be within acceptable limits, and its efficacy for producing fast and complete recanalization is promising, but a larger cohort of patients is required to confirm these preliminary observations.

publication date

  • August 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1001/archneur.63.8.1057

PubMed ID

  • 16908730

Additional Document Info

start page

  • 1057

end page

  • 62

volume

  • 63

number

  • 8